Reason for request
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.
Clinical Benefit
| Substantial |
The actual benefit of this proprietary medicinal product is substantial. |
Clinical Added Value
| no clinical added value |
VISANNE does not provide an improvement in actual benefit (IAB V) in the therapeutic strategy for endometriosis. |
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
WmEXgp52w6GxdVam
Listen
